2009 Chemical and Biological Defense Science and Technology Conference

THURSDAY, 19 NOVEMBER 2009

Session: Pathogen-directed Therapeutics
Chair: "Gary" Guilin Qiao
1400 - 1430 Subramanyam Swaminathan, Brookhaven National Laboratory 
  Mode of VAMP Recognition by Botulinum Neurotoxin F and Its Implication in Drug Design
1430 - 1500 Patrick McNutt, USAMRICD 
  Development of Embryonic Stem Cell-Derived Neurons as Moderate-Throughput Discovery Platform for Botulinum Inhibitors
1500 - 1530 Break
1530 - 1600 Yuan-Ping Pang, Mayo Clinic 
  Potent New Small-Molecule Inhibitor of Botulinum Neurotoxin Serotype A Endopeptidase Developed by Synthesis-Based Computer-Aided Molecular Design
1600 - 1630 Jon Davis, US Army Medical Research Institute of Infectious Diseases 
  Development of Small Molecule Inhibitors of Botulinum neurotoxin serotype A
Return to previous page
Privacy Policy